Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma
NCT03881501
·
clinicaltrials.gov ↗
UNKNOWN
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma Non-resectable
Sponsor
Huazhong University of Science and Technology